Form 4: Director Wayne Burris Receives 66,667 Restricted Stock Units in Accelerate Diagnostics, Inc.

Wayne Burris, a director of Accelerate Diagnostics, Inc., was granted 66,667 restricted stock units (RSUs) on May 20, 2024, which vest on the first anniversary of the grant date.

Summary

• On May 20, 2024, Wayne Burris, a director of Accelerate Diagnostics, Inc., received 66,667 restricted stock units (RSUs).
• These RSUs represent a contingent right to receive one share of the issuer's common stock upon vesting.
• The RSUs vest on the first-year anniversary of the grant date.
• If the reporting person leaves in good standing before the vesting date, the RSUs will vest pro-rata based on months served.
• Burris has elected to defer receipt of the shares of common stock upon vesting of the RSUs to a time within 30 days following his departure from the issuer's board of directors, pursuant to the issuer's Director Equity Deferral Program.

Sentiment

Score: 7

Explanation: The document reflects a routine grant of stock units, which is generally viewed neutrally to positively as it aligns director interests with shareholders. There are no indications of negative news or concerns.

Positives

• The grant of RSUs aligns the director's interests with the long-term performance of the company.
• The vesting schedule encourages continued service on the board.

Future Outlook

The reporting person has elected to defer receipt of the shares of common stock upon vesting of the RSUs to such time that is within 30 days following the reporting person's departure from the issuer's board of directors.

Industry Context

This is a standard practice for compensating board members in publicly traded companies, aligning their interests with shareholders.

Comparison to Industry Standards

• Director compensation packages often include a mix of cash and equity.
• RSUs are a common form of equity compensation, vesting over a period of years to incentivize long-term commitment.
• Companies like Danaher and Thermo Fisher Scientific also use similar equity-based compensation for their board members.

Stakeholder Impact

• Shareholders may view the RSU grant positively as it aligns the director's interests with the company's long-term success.
• Employees are not directly impacted by this transaction.

Key Dates